Free Trial

Avalo Therapeutics (AVTX) Insider Trading & Ownership

Avalo Therapeutics logo
$10.13 +0.48 (+4.97%)
(As of 11/22/2024 ET)

Avalo Therapeutics (NASDAQ:AVTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.25%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$6,250.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get AVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AVTX Insider Buying and Selling by Quarter

Avalo Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/12/2024June Sherie AlmenoffDirectorBuy500$12.50$6,250.00  
(Data available from 1/1/2013 forward)

AVTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Avalo Therapeutics includes Armistice Capital, Llc, Caissa Capital Management Ltd., Christopher Ryan Sullivan, Garry Arthur Neil, H Jeffrey Wilkins, June Sherie Almenoff, and Schond L Greenway. Learn more on insiders at AVTX.

0.25% of Avalo Therapeutics stock is owned by insiders. Learn more on AVTX's insider holdings.

The following insiders have purchased AVTX shares in the last 24 months: Caissa Capital Management Ltd. ($353,508.00), Christopher Ryan Sullivan ($1,641.60), Garry Arthur Neil ($21,619.20), and June Sherie Almenoff ($6,250.00).

Insiders have purchased a total of 1,035 AVTX shares in the last 24 months for a total of $383,018.80 bought.

The following insider sold AVTX shares in the last 24 months: Armistice Capital, Llc ($1,675,108.80).

Insiders have sold a total of 11,442 Avalo Therapeutics shares in the last 24 months for a total of $1,675,108.80 sold.

Avalo Therapeutics Key Executives

  • Dr. Garry A. Neil M.D. (Age 70)
    Chairman of the Board, President & CEO
    Compensation: $475k
  • Mr. Christopher Ryan SullivanMr. Christopher Ryan Sullivan (Age 40)
    CFO & Head of Investor relations
    Compensation: $350k
  • Dr. Solomon H. Snyder M.D. (Age 85)
    Founder and Chairman of Scientific Advisory Board
  • Dr. Barbara S. Slusher Ph.D. (Age 59)
    Founder and Member of Scientific Advisory Board
  • Dr. Lisa Hegg Ph.D.
    Senior Vice President of Program Management, Corporate Infrastructure & Clinical Operations
  • Ms. Colleen Matkowski
    Senior Vice President of Global Regulatory Affairs & Quality Assurance
  • Dr. Dino C. Miano Ph.D.
    Senior Vice President of CMC & Technical Operations


This page (NASDAQ:AVTX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners